Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis X Liu, L Nie, Y Zhang, Y Yan, C Wang, M Colic, K Olszewski, A Horbath, ... Nature cell biology 25 (3), 404-414, 2023 | 327 | 2023 |
Identifying chemogenetic interactions from CRISPR screens with drugZ M Colic, G Wang, M Zimmermann, K Mascall, M McLaughlin, L Bertolet, ... Genome medicine 11, 1-12, 2019 | 158 | 2019 |
A network of human functional gene interactions from knockout fitness screens in cancer cells E Kim, M Dede, WF Lenoir, G Wang, S Srinivasan, M Colic, T Hart Life science alliance 2 (2), 2019 | 86 | 2019 |
Genome-wide in vivo CNS screening identifies genes that modify CNS neuronal survival and mHTT toxicity MH Wertz, MR Mitchem, SS Pineda, LJ Hachigian, H Lee, V Lau, ... Neuron 106 (1), 76-89. e8, 2020 | 73 | 2020 |
CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions D Su, X Feng, M Colic, Y Wang, C Zhang, C Wang, M Tang, T Hart, ... DNA repair 87, 102803, 2020 | 24 | 2020 |
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells WF Lenoir, M Morgado, PC DeWeirdt, M McLaughlin, AL Griffith, ... Nature communications 12 (1), 6506, 2021 | 21 | 2021 |
Common computational tools for analyzing CRISPR screens M Colic, T Hart Emerging topics in life sciences 5 (6), 779-788, 2021 | 15 | 2021 |
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactions E Kim, LC Novak, C Lin, M Colic, LL Bertolet, V Gheorghe, CA Bristow, ... Genome biology 23 (1), 140, 2022 | 10 | 2022 |
Chemogenetic interactions in human cancer cells M Colic, T Hart Computational and Structural Biotechnology Journal 17, 1318-1325, 2019 | 10 | 2019 |
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase Y Yoshihama, KA LaBella, E Kim, L Bertolet, M Colic, J Li, X Shang, ... Proceedings of the National Academy of Sciences 118 (36), e2026324118, 2021 | 7 | 2021 |
Identifying chemogenetic interactions from CRISPR screens with drugZ. Genome Med. 2019; 11: 52 M Colic, G Wang, M Zimmermann, K Mascall, M McLaughlin, L Bertolet | 6 | |
Combined genome-scale fitness and paralog synthetic lethality screens with just 44k clones: the IN4MER CRISPR/Cas12a multiplex knockout platform. C Lin, LL Wilson, AK Sangree, X Ma, M Colic, JG Doench, T Hart Biorxiv: the Preprint Server for Biology, 2023 | 4 | 2023 |
PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screens LC Novak, J Chou, M Colic, CA Bristow, T Hart Nucleic acids research 51 (D1), D1117-D1121, 2023 | 2 | 2023 |
Efficient gene knockout and genetic interactions: the IN4MER CRISPR/Cas12a multiplex knockout platform NE Anvar, C Lin, X Ma, LL Wilson, R Steger, AK Sangree, M Colic, ... bioRxiv, 2023 | 2 | 2023 |
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform N Esmaeili Anvar, C Lin, X Ma, LL Wilson, R Steger, AK Sangree, M Colic, ... Nature Communications 15 (1), 3577, 2024 | 1 | 2024 |
Single-molecule single-cell DNA sequencing identifies ongoing copy number evolution in BRCA breast cancers H Du, A Davis, R Gao, M Colic, E Sei, M Hu, AG Barrera, A Casasent, ... Cancer Research 78 (13_Supplement), 2192-2192, 2018 | 1 | 2018 |
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon Y Zhu, D Zhang, P Shukla, YH Jung, PB Malgulwar, S Chagani, M Colic, ... JCI insight 9 (2), 2024 | | 2024 |
EXPLOITING CHEMOGENETIC AND GENETIC INTERACTIONS IN HUMAN CELLS AS AN AVENUE FOR NEW THERAPEUTIC OPPORTUNITIES M Colic | | 2022 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 J Błasiak Autophagy 17 (1), 2021 | | 2021 |
Discovery of novel tumor suppressors from CRISPR screens reveals lipid-sensitive subtype of AML WF Lenoir, M Morgado, PC DeWeirdt, M McLaughlin, AL Griffith, ... Hematology. American Society of Hematology. Education Program, 2020 | | 2020 |